STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Blog
investing

Oracle Rebounds as Big Tech’s AI Spending Revives Software Optimism

byLuca Blaumann
February 9, 2026
in Blog
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

Massive cloud capex plans ease fears that AI will sideline enterprise software

Oracle Corp. (ORCL) shares surged Monday, extending a sharp rebound as renewed confidence in Big Tech’s capital spending helped calm investor fears that artificial intelligence could erode demand for traditional software. The stock rallied as much as 12% intraday—its biggest single-day jump since September—despite remaining roughly 50% below its highs from last fall.

The catalyst came from escalating investment commitments across the technology sector. Amazon.com Inc. recently pledged to spend about $200 billion this year on data centers, chips, and infrastructure, reinforcing the view that AI’s next phase will require not just hardware, but robust software to manage, deploy, and monetize those systems. Similar spending plans from Alphabet Inc., Meta Platforms Inc., and Microsoft Corp. have underscored that AI budgets are expanding, not contracting.

That shift has prompted some analysts to rethink the narrative that AI will “vibe code” software vendors out of relevance. D.A. Davidson analyst Gil Luria upgraded Oracle to a buy, arguing that enterprises will continue paying for its database and cloud products as AI workloads scale. He also expressed growing confidence in Oracle’s partnership with OpenAI, citing strategic changes, improved fundraising prospects, and competitive pressure on Google’s rivals.

The broader software sector has been under pressure, with fears that AI could commoditize application development dragging valuations lower. Yet optimists argue that a meaningful portion of the roughly $650 billion earmarked for AI tools by hyperscalers will ultimately flow to software providers that enable deployment, security, and data management.

Skeptics remain. Melius Research analyst Ben Reitzes cautioned that Oracle’s cash generation remains challenged and that OpenAI’s long-term dominance is far from guaranteed amid competition from Anthropic and Google. Still, Oracle is pressing ahead, planning to raise $45–$50 billion to expand capacity for major customers including Nvidia Corp., Advanced Micro Devices, and Meta.

For now, Oracle’s rally suggests investors are warming to the idea that AI’s explosive growth may ultimately reinforce—rather than replace—the role of enterprise software.

You might like this article:Hims & Hers Shares Plunge as FDA Tightens Grip on Compounded GLP-1 Drugs

Tags: GrowthMoversNewsORCLSPYStock Market
Previous Post

Hims & Hers Shares Plunge as FDA Tightens Grip on Compounded GLP-1 Drugs

Next Post

FDA Flags Novo Nordisk’s Wegovy Pill Ad for Misleading Claims

Related Posts

drugs-2

FDA Flags Novo Nordisk’s Wegovy Pill Ad for Misleading Claims

byLuca Blaumann
February 9, 2026
0

Regulatory scrutiny adds pressure as competition intensifies in the booming GLP-1 market Food and Drug Administration has issued a warning...

Nasdaq Rises Ahead of Fed Meeting as Tech Stocks Rally and M&A Activity Heats Up

byLuca Blaumann
December 8, 2025
0

Broadcom–Microsoft chip talks, IBM’s $11B Confluent deal, and a hostile bid for Warner Bros. Discovery add momentum to a market...

EXCLUSIVE: MIRA Pharmaceuticals’ Disruptive Path In Neurology And Metabolic Disorders

byLiliana Vida
June 30, 2025
0

CEO Erez Aminov on Breakthrough Drug Candidates, Strategic Acquisitions, and the Vision Behind MIRA’s Innovation-Driven Pipeline MIRA Pharmaceuticals (NASDAQ: MIRA),...

Next Post
drugs-2

FDA Flags Novo Nordisk’s Wegovy Pill Ad for Misleading Claims

Latest News

FDA Flags Novo Nordisk’s Wegovy Pill Ad for Misleading Claims

Oracle Rebounds as Big Tech’s AI Spending Revives Software Optimism

Hims & Hers Shares Plunge as FDA Tightens Grip on Compounded GLP-1 Drugs

Stellantis Takes $26 Billion EV Write-Down as Electrification Strategy Resets

Dentsply Sirona’s $45 Bull Case: A Turnaround Leveraged to a Dental Recovery

Based on Your Interest

Entertainment

Reddit Enters a New Growth Era as Profits Surge and Share Buyback Signals Confidence

February 5, 2026
amazon
Ecommerece

Amazon Beats Earnings, but Massive AI Spending Spooks Investors

February 5, 2026
Gold

Silver’s Historic Rout Exposes the Dark Side of Speculative Mania

February 5, 2026

Recommended

Artificial Intelligence

Alphabet’s AI Bet Shakes Investors, but Fundamentals Stay Strong

February 5, 2026
Bitcoin

Bitcoin Slides After Treasury Pushback Signals No Government Backstop

February 4, 2026
Artificial Intelligence

Advanced Micro Devices Beats Earnings, but Shares Slide as AI Expectations Stay Sky-High

February 4, 2026
Artificial Intelligence

Intel Signals GPU Ambitions in Bid to Reclaim Data Center Relevance

February 3, 2026
Artificial Intelligence

Earnings Season Hits a Crucial Stretch as Tech Strength Meets Consumer Caution

February 3, 2026
Stoxpo

Follow us on social media:

Highlights

  • FDA Flags Novo Nordisk’s Wegovy Pill Ad for Misleading Claims
  • Oracle Rebounds as Big Tech’s AI Spending Revives Software Optimism
  • Hims & Hers Shares Plunge as FDA Tightens Grip on Compounded GLP-1 Drugs
  • Stellantis Takes $26 Billion EV Write-Down as Electrification Strategy Resets
  • Dentsply Sirona’s $45 Bull Case: A Turnaround Leveraged to a Dental Recovery

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

drugs-2

FDA Flags Novo Nordisk’s Wegovy Pill Ad for Misleading Claims

February 9, 2026
investing

Oracle Rebounds as Big Tech’s AI Spending Revives Software Optimism

February 9, 2026
drugs-4

Hims & Hers Shares Plunge as FDA Tightens Grip on Compounded GLP-1 Drugs

February 9, 2026
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.